The link between the sphingolipid rheostat and obstructive sleep apnea

Abstract Chronic inflammation induced by hypoxia during sleep is an important mechanism of microvascular damage in OSA patients. In this study, we investigated the role of the sphingosine rheostat, which has diverse inflammatory effects. Thirty-seven healthy subjects and 31 patients with OSA were re...

Full description

Bibliographic Details
Main Authors: Péter Horváth, Lilla Büdi, Dániel Hammer, Rita Varga, György Losonczy, Ádám Domonkos Tárnoki, Dávid László Tárnoki, Martina Mészáros, András Bikov
Format: Article
Language:English
Published: Nature Portfolio 2023-05-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-34717-4
_version_ 1797827596326535168
author Péter Horváth
Lilla Büdi
Dániel Hammer
Rita Varga
György Losonczy
Ádám Domonkos Tárnoki
Dávid László Tárnoki
Martina Mészáros
András Bikov
author_facet Péter Horváth
Lilla Büdi
Dániel Hammer
Rita Varga
György Losonczy
Ádám Domonkos Tárnoki
Dávid László Tárnoki
Martina Mészáros
András Bikov
author_sort Péter Horváth
collection DOAJ
description Abstract Chronic inflammation induced by hypoxia during sleep is an important mechanism of microvascular damage in OSA patients. In this study, we investigated the role of the sphingosine rheostat, which has diverse inflammatory effects. Thirty-seven healthy subjects and 31 patients with OSA were recruited. We collected data on demographics and comorbidities. Plasma sphingosine-1-phosphate and ceramide antibody concentrations were measured by ELISA. The results were compared between the OSA and control groups, and the correlations between these measurements and markers of disease severity and comorbidities were explored. Ceramide antibody levels were significantly elevated in OSA patients (892.17 ng/ml) vs. controls (209.55 ng/ml). S1P levels were also significantly higher in patients with OSA (1760.0 pg/ml) than in controls (290.35 pg/ml, p < 0.001). The ceramide antibody concentration showed correlations with BMI (ρ = 0.25, p = 0.04), CRP (ρ = 0.36, p = 0.005), AHI (ρ = 0.43, p < 0.001), ODI (ρ = 0.43, p < 0.001), TST90% (ρ = 0.35, p = 0.004) and the lowest oxygen saturation (ρ =  0.37, p = 0.001) in the whole study population but not when patients with OSA were analyzed separately. The elevated ceramide antibody and sphingosine-1-phosphate concentrations in patients suffering from OSA suggests their involvement in the pathomechanism of OSA and its comorbidities.
first_indexed 2024-04-09T12:50:51Z
format Article
id doaj.art-bab4b6bb5b2647e5a4b588bb589a79ee
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-09T12:50:51Z
publishDate 2023-05-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-bab4b6bb5b2647e5a4b588bb589a79ee2023-05-14T11:13:05ZengNature PortfolioScientific Reports2045-23222023-05-011311810.1038/s41598-023-34717-4The link between the sphingolipid rheostat and obstructive sleep apneaPéter Horváth0Lilla Büdi1Dániel Hammer2Rita Varga3György Losonczy4Ádám Domonkos Tárnoki5Dávid László Tárnoki6Martina Mészáros7András Bikov8Department of Pulmonology, Semmelweis UniversityDepartment of Pulmonology, Semmelweis UniversityDepartment of Pulmonology, Semmelweis UniversityDepartment of Pulmonology, Semmelweis UniversityDepartment of Pulmonology, Semmelweis UniversityMedical Imaging Centre, Semmelweis UniversityMedical Imaging Centre, Semmelweis UniversityUniversity Hospital ZürichManchester University NHS Foundation TrustAbstract Chronic inflammation induced by hypoxia during sleep is an important mechanism of microvascular damage in OSA patients. In this study, we investigated the role of the sphingosine rheostat, which has diverse inflammatory effects. Thirty-seven healthy subjects and 31 patients with OSA were recruited. We collected data on demographics and comorbidities. Plasma sphingosine-1-phosphate and ceramide antibody concentrations were measured by ELISA. The results were compared between the OSA and control groups, and the correlations between these measurements and markers of disease severity and comorbidities were explored. Ceramide antibody levels were significantly elevated in OSA patients (892.17 ng/ml) vs. controls (209.55 ng/ml). S1P levels were also significantly higher in patients with OSA (1760.0 pg/ml) than in controls (290.35 pg/ml, p < 0.001). The ceramide antibody concentration showed correlations with BMI (ρ = 0.25, p = 0.04), CRP (ρ = 0.36, p = 0.005), AHI (ρ = 0.43, p < 0.001), ODI (ρ = 0.43, p < 0.001), TST90% (ρ = 0.35, p = 0.004) and the lowest oxygen saturation (ρ =  0.37, p = 0.001) in the whole study population but not when patients with OSA were analyzed separately. The elevated ceramide antibody and sphingosine-1-phosphate concentrations in patients suffering from OSA suggests their involvement in the pathomechanism of OSA and its comorbidities.https://doi.org/10.1038/s41598-023-34717-4
spellingShingle Péter Horváth
Lilla Büdi
Dániel Hammer
Rita Varga
György Losonczy
Ádám Domonkos Tárnoki
Dávid László Tárnoki
Martina Mészáros
András Bikov
The link between the sphingolipid rheostat and obstructive sleep apnea
Scientific Reports
title The link between the sphingolipid rheostat and obstructive sleep apnea
title_full The link between the sphingolipid rheostat and obstructive sleep apnea
title_fullStr The link between the sphingolipid rheostat and obstructive sleep apnea
title_full_unstemmed The link between the sphingolipid rheostat and obstructive sleep apnea
title_short The link between the sphingolipid rheostat and obstructive sleep apnea
title_sort link between the sphingolipid rheostat and obstructive sleep apnea
url https://doi.org/10.1038/s41598-023-34717-4
work_keys_str_mv AT peterhorvath thelinkbetweenthesphingolipidrheostatandobstructivesleepapnea
AT lillabudi thelinkbetweenthesphingolipidrheostatandobstructivesleepapnea
AT danielhammer thelinkbetweenthesphingolipidrheostatandobstructivesleepapnea
AT ritavarga thelinkbetweenthesphingolipidrheostatandobstructivesleepapnea
AT gyorgylosonczy thelinkbetweenthesphingolipidrheostatandobstructivesleepapnea
AT adamdomonkostarnoki thelinkbetweenthesphingolipidrheostatandobstructivesleepapnea
AT davidlaszlotarnoki thelinkbetweenthesphingolipidrheostatandobstructivesleepapnea
AT martinameszaros thelinkbetweenthesphingolipidrheostatandobstructivesleepapnea
AT andrasbikov thelinkbetweenthesphingolipidrheostatandobstructivesleepapnea
AT peterhorvath linkbetweenthesphingolipidrheostatandobstructivesleepapnea
AT lillabudi linkbetweenthesphingolipidrheostatandobstructivesleepapnea
AT danielhammer linkbetweenthesphingolipidrheostatandobstructivesleepapnea
AT ritavarga linkbetweenthesphingolipidrheostatandobstructivesleepapnea
AT gyorgylosonczy linkbetweenthesphingolipidrheostatandobstructivesleepapnea
AT adamdomonkostarnoki linkbetweenthesphingolipidrheostatandobstructivesleepapnea
AT davidlaszlotarnoki linkbetweenthesphingolipidrheostatandobstructivesleepapnea
AT martinameszaros linkbetweenthesphingolipidrheostatandobstructivesleepapnea
AT andrasbikov linkbetweenthesphingolipidrheostatandobstructivesleepapnea